Key Events This Week
Jan 5: Technical upgrades signal bullish momentum
Jan 6: Mojo Grade downgraded to Hold amid mixed signals
Jan 7: New 52-week high reached at Rs.1,921.1
Jan 8: Price retreats amid heavy put options activity
Jan 9: Week closes at Rs.1,888.10 (-1.13%)
Why is J B Chemicals & Pharmaceuticals Ltd falling/rising?
2026-01-08 01:58:10
Strong Price Performance Against Benchmarks
The stock has outperformed key market indices and its sector peers over recent periods. Over the past week, J B Chemicals & Pharmaceuticals Ltd gained 6.26%, while the Sensex declined by 0.30%. This positive trend extends to the one-month and year-to-date periods, with the stock rising 6.06% and 6.26% respectively, contrasting with the Sensex’s negative returns. Although the stock’s one-year return of 2.81% trails the Sensex’s 8.65%, its longer-term performance is impressive, with a three-year gain of 98.42% compared to the Sensex’s 41.84%, and a five-year return of 273.82% far exceeding the benchmark’s 76.66%. These figures underscore the company’s sustained growth trajectory and investor confidence over time.
Te...
Read full news article
J B Chemicals & Pharmaceuticals Ltd Hits New 52-Week High at Rs.1921.1
2026-01-07 12:55:58J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.1921.1, marking a notable moment in the stock’s recent performance and reflecting sustained momentum in the Pharmaceuticals & Biotechnology sector.
Read full news article
J B Chemicals & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-01-07 08:09:36J B Chemicals & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical signals across multiple timeframes. The stock’s recent performance, coupled with upgrades in its technical trend and a revised Mojo Grade, suggests a cautiously optimistic outlook for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
J B Chemicals & Pharmaceuticals Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-01-06 08:14:13J B Chemicals & Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 5 January 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite strong fundamentals and robust institutional backing, evolving market dynamics and valuation concerns have tempered enthusiasm for the stock in the near term.
Read full news article
J B Chemicals & Pharmaceuticals Ltd: Technical Momentum Shifts Signal Cautious Outlook
2026-01-06 08:12:50J B Chemicals & Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish stance. While daily moving averages and weekly MACD indicators suggest positive momentum, monthly signals reveal caution, reflecting a complex interplay of market forces for this pharmaceuticals & biotechnology player.
Read full news article
J B Chemicals & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-01-05 08:03:24J B Chemicals & Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Hold to Buy as of 31 Dec 2025. The stock’s recent performance and technical signals suggest a strengthening trend that investors should closely monitor amid a competitive pharmaceuticals and biotechnology sector.
Read full news articleJ B Chemicals Gains 1.51%: Technical Upgrades and Mixed Momentum Shape Week
2026-01-04 13:03:00
Key Events This Week
29 Dec 2025: Stock opens week at Rs.1,799.65, down 0.95%
31 Dec 2025: Mojo Grade upgraded to Buy; stock gains 1.22% to Rs.1,820.45
1 Jan 2026: Technical momentum confirmed amid bullish indicators
2 Jan 2026: Mildly bullish trend with mixed signals; closes at Rs.1,844.40 (+1.55%)
JB Chemicals & Pharmaceuticals Limited - Updates
28-Nov-2019 | Source : NSEJB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Approval for re-classification of certain promoter group members to public'.
JB Chemicals & Pharmaceuticals Limited - Other General Purpose
21-Nov-2019 | Source : NSEJB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
JB Chemicals & Pharmaceuticals Limited - Public Announcement-Buyback of Shares
14-Nov-2019 | Source : NSEJB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of Public Announcement - Buyback of Shares.
Corporate Actions
No Upcoming Board Meetings
J B Chemicals & Pharmaceuticals Ltd has declared 700% dividend, ex-date: 30 Jul 25
J B Chemicals & Pharmaceuticals Ltd has announced 1:2 stock split, ex-date: 18 Sep 23
No Bonus history available
No Rights history available







